Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.
作者信息
Kalliolias George D, Georgiou Panagiotis E, Antonopoulos Ioannis A, Andonopoulos Andrew P, Liossis Stamatis-Nick C
出版信息
Ann Rheum Dis. 2007 Jun;66(6):842-3. doi: 10.1136/ard.2006.066381.
Abstract
摘要
相似文献
1
Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.
Ann Rheum Dis. 2007 Jun;66(6):842-3. doi: 10.1136/ard.2006.066381.
2
Adult-onset Still's disease in a patient with cystic fibrosis and its successful treatment with anakinra.
Rheumatology (Oxford). 2012 Sep;51(9):1730-2. doi: 10.1093/rheumatology/kes040. Epub 2012 Apr 17.
3
Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
J Rheumatol. 2008 May;35(5):939-41.
4
IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.
Ann Rheum Dis. 2010 Feb;69(2):466-7. doi: 10.1136/ard.2009.108068.
5
Early use of anakinra in adult-onset Still's disease myocarditis.
Scand J Rheumatol. 2018 Nov;47(6):511-512. doi: 10.1080/03009742.2017.1387672. Epub 2018 Jan 2.
6
Anakinra in children and adults with Still's disease.
Rheumatology (Oxford). 2019 Nov 1;58(Suppl 6):vi9-vi22. doi: 10.1093/rheumatology/kez350.
7
Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still's disease.
Mod Rheumatol. 2010 Apr;20(2):200-4. doi: 10.1007/s10165-009-0254-1.
8
Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra.
Joint Bone Spine. 2011 Jan;78(1):100-1. doi: 10.1016/j.jbspin.2010.09.014. Epub 2010 Oct 30.
9
Long-term efficacy and safety of Anakinra in a patient with liver transplant due to Adult onset Still's Disease.
Mod Rheumatol. 2014 Nov;24(6):1030-1. doi: 10.3109/14397595.2013.854437. Epub 2013 Dec 6.
10
Efficacy of anakinra in a case of refractory Still disease.
J Clin Rheumatol. 2008 Dec;14(6):357-8. doi: 10.1097/RHU.0b013e318188b8d8.
引用本文的文献
1
Anakinra in the management of adult-onset still's disease: a single-center experience.
Intern Emerg Med. 2025 Jan;20(1):131-138. doi: 10.1007/s11739-024-03766-6. Epub 2024 Sep 16.
2
The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation.
Front Pediatr. 2023 Mar 13;11:1130013. doi: 10.3389/fped.2023.1130013. eCollection 2023.
3
The Role of the Interleukin-1 Family in Complications of Prematurity.
Int J Mol Sci. 2023 Feb 1;24(3):2795. doi: 10.3390/ijms24032795.
4
Successful treatment of interstitial pneumonitis with anakinra in a patient with adult-onset Still's disease.
Eur J Hosp Pharm. 2021 Nov;28(6):346-349. doi: 10.1136/ejhpharm-2020-002377. Epub 2020 Aug 11.
5
Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.
Arthritis Res Ther. 2019 Dec 11;21(1):275. doi: 10.1186/s13075-019-2021-9.
6
Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still's Disease.
Clin Rev Allergy Immunol. 2020 Feb;58(1):71-81. doi: 10.1007/s12016-019-08747-8.
7
Mechanisms, biomarkers and targets for adult-onset Still's disease.
Nat Rev Rheumatol. 2018 Oct;14(10):603-618. doi: 10.1038/s41584-018-0081-x.
8
Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.
Drugs. 2018 Aug;78(12):1187-1195. doi: 10.1007/s40265-018-0956-9.
9
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.
Clin Rheumatol. 2016 Jul;35(7):1683-9. doi: 10.1007/s10067-016-3308-8. Epub 2016 May 20.
10
A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?
Clin Rheumatol. 2016 Aug;35(8):2117-2123. doi: 10.1007/s10067-015-3164-y. Epub 2016 Jan 12.
本文引用的文献
1
Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution?
Ann Rheum Dis. 2005 Oct;64(10):1523-4. doi: 10.1136/ard.2005.042945. Epub 2005 Jul 13.
2
Rapid responses to anakinra in patients with refractory adult-onset Still's disease.
Arthritis Rheum. 2005 Jun;52(6):1794-803. doi: 10.1002/art.21061.
3
Blocking IL-1 in systemic inflammation.
J Exp Med. 2005 May 2;201(9):1355-9. doi: 10.1084/jem.20050640.
4
Refractory adult onset Still's disease successfully treated with anakinra.
Ann Rheum Dis. 2005 Apr;64(4):647-8. doi: 10.1136/ard.2004.026617. Epub 2004 Sep 16.
5
Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.
Ann Rheum Dis. 2005 Feb;64(2):262-6. doi: 10.1136/ard.2004.024026. Epub 2004 Jun 7.
6
Adult Still's disease: review of 228 cases from the literature.
J Rheumatol. 1987 Dec;14(6):1139-46.
7
Preliminary criteria for classification of adult Still's disease.
J Rheumatol. 1992 Mar;19(3):424-30.
Zotero 插件